Previously banned drug becomes anti-cancer superhero
Cancer Multiple Myeloma Thalidomide

Previously banned drug becomes anti-cancer superhero

Dr Pratap Acharya
Dr Pratap Acharya

Recent studies support thalidomide’s use against blood cancers like multiple myeloma (MM) and suggest that the drug can help target cancer-promoting agents that were previously drug resistant. Additionally, it produced better survival rates in MM patients than other drugs in a recent trial.

In 10 seconds? Thalidomide, notorious for birth defects in the 1960s is now routinely used to treat multiple myeloma, but researchers have discovered more of its hidden powers that can help target other cancers.

Try Sparrow today

  • Read the latest science updates in just three minutes
  • Get five Digests emailed to you every week—100% free
  • No angle. No agenda. Just the facts.
  • Premium subscribers get access to the complete Sparrow library